INNOVATIVE RESEARCH & EDUCATION
The Institute for Biomedical Sciences is training future generations of leading biomedical scientists and professionals through a unique approach to education that highlights the connection among science, business and law and teaches sought-after, technical skills in our advanced labs. Our world-class researchers are tackling some of the most urgent human diseases such as COVID-19, developing new vaccines, diagnostics and therapeutics in research centers focused on microbial pathogenesis, translational immunology and inflammation, immunity and infection.
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute for Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the institute each year, and the university is planning even more expansion.
Explore Our Programs
Biomedical Science Research
STOPPING A GLOBAL KILLER
FIGHTING DISEASE THREATS
While humans have encountered some deadly viruses over the centuries such as influenza, Ebola, smallpox, SARS, MERS and HIV, there are inevitably new, life-threatening diseases out there waiting to emerge. Experts have agreed that it wasn’t a question of if – but when – another lethal infectious agent would occur and speculated if the world would be ready to fight it. Sadly, the answer is no.
News Stories & Events
More
Top Stories
Tackling Emerging Viruses
Caroline Williams earned her Ph.D. in Translational Biomedical Sciences by embarking upon studies of two newly emerging viruses, SARS-CoV-2, the virus that causes COVID-19, and Mengla virus, a newly identified filovirus.read more ❯
Georgia State Recognized in White House Press Briefing for Contribution to Research on Antiviral Drug Recommended to Treat COVID-19
Georgia State University was highlighted in a press briefing Oct. 6 by the White House COVID-19 response team, which recognized the university’s contribution to groundbreaking research that led to the development of molnupiravir.read more ❯
Oral Drug Tested at Georgia State Recommended for Emergency Use Authorization to Treat COVID-19
A new antiviral drug tested in the Institute for Biomedical Sciences at Georgia State against influenza virus and SARS-CoV-2 has been recommended for emergency use authorization to treat COVID-19 in the United States by pharmaceutical companies that completed a Phase 3 clinical trial and achieved promising results. read more ❯